Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• 主要な著者: Rachel S Laufer (著者), Ranju Baral (著者), Andrea G Buchwald (著者), James D Campbell (著者), Flanon Coulibaly (著者), Fatoumata Diallo (著者), Moussa Doumbia (著者), Amanda J Driscoll (著者), Alison P Galvani (著者), Adama M Keita (著者), Kathleen M Neuzil (著者), Samba Sow (著者), Clint Pecenka (著者), Justin R Ortiz (著者), Meagan C Fitzpatrick (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...